Explore evidence

24 %Among 31,405 first-time volunteer blood donors in Burkina Faso in 2009, 24.0% were infected with at least one pathogen.

Burkina Fasotransfusion-transmitted infectious diseasesobserved 2009published 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 9 observationsDOI 10.1111/j.1365-3156.2011.02902.x

24.11 %The prevalence of HPV-50'S among HPV-positive women in Burkina Faso was 24.11%.

Burkina FasoHPV-50'Sobserved February 2009 to January 2010published 2010Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 13 observations

5.9 %The overall alloimmunisation rate was 5.9% among 235 multi-transfused chronic renal failure patients in Burkina Faso.

Burkina Fasochronic renal failureobserved October 2018 to November 2019published 2022African journal of laboratory medicineeurope_pmcdocument of 3 observationsDOI 10.4102/ajlm.v11i1.1625

Haemoglobin level was influenced by msp2 family with patients harboring the FC27 allele showing lower haemoglobin level than mono-infected individuals by the 3D7 allele.

Burkina Fasopaludismepublished 2019Scientific reportseurope_pmcdocument of 4 observationsDOI 10.1038/s41598-018-36493-y

39.4 %The specificity of CRP at ≥20 mg/L for detection of bacteremia in patients aged ≥ 5 years was 39.4%.

Burkina Fasobacteraemiapublished 2021PLoS neglected tropical diseaseseurope_pmcdocument of 11 observations

5.1 %Among 198 blood donors in Ouagadougou, Burkina Faso, 10 (5.1%) were positive for Epstein-Barr virus (EBV).

Burkina Fasovirus Epstein-Barrpublished 2016The Pan African medical journaleurope_pmcdocument of 8 observations

202 casesThe study included 202 cases and 204 matched controls subjects for essential hypertension in the population of Burkina Faso.

Burkina Fasoessential hypertensionpublished 2015International journal of hypertensioneurope_pmcdocument of 7 observationsDOI 10.1155/2015/979631

5 patientsRescue therapy was required in 5 out of 8 teenaged patients treated with SAR97276A twice daily (0.25 mg/kg) for 3 days.

Burkina Fasopaludismepublished 2017Malaria journaleurope_pmcdocument of 5 observationsDOI 10.1186/s12936-017-1832-x

146 mmFollowing paracentesis, the median value of the Ascites Index was 146 mm in cancer patients.

Burkina Fasocancer (non précisé)published 2018Journal of ultrasonographyeurope_pmcdocument of 5 observations

40.2 %La prévalence de l’HTA était de 40,2 % au Burkina Faso.

Burkina Fasohypertension artérielleHAL · Unilimdocument of 674 observations

0.54 odds_ratioThe haplotype GGT from the rs6001417, rs8177832 and rs35228531 SNPs has a protective effect against HIV-1 infection with an odds ratio of 0.54 [0.43–0.68] and p-value < 0.001.

Burkina FasoVIH/sidapublished 2016PloS oneeurope_pmcdocument of 4 observations

55.8 %Vaccine efficacy of RTS,S/AS01 against clinical malaria was 55.8% in the per-protocol population.

Burkina Fasopaludismepublished 2011The New England journal of medicineeurope_pmcdocument of 7 observationsDOI 10.1056/nejmoa1102287

97.4 %The specificity of db-PCR-NALFIA compared to the initial diagnosis in the laboratory was 97.4%.

Burkina Fasopaludismepublished 2012Journal of clinical microbiologyeurope_pmcdocument of 10 observations

1.7 visitsThe mean visit number on which the DHFR-TS-ELISA was still positive after treatment was 1.7 visits with a 95% confidence interval of 1.1 to 2.3.

Burkina Fasopaludismepublished 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observations

23 %Sabatinelli et al. (1986) estimated that 23% of malaria-related deaths recorded worldwide are attributable to environmental factors.

Burkina Fasopaludismeobserved 1986HAL · Unilimdocument of 110 observations

The strong correlation between HAV reads and qPCR viral loads suggests that mNGS could be used for the quantification of the viral load in HAV infections.

Burkina FasoHAVHAL · Unilimdocument of 26 observations

7.8 %ENT infections accounted for 7.8% of fever aetiologies among the 306 patients.

Burkina FasoENT infectionsHAL · Unilimdocument of 83 observations

0.787 p_valueNo significant difference was observed (t = 0.2896, df = 4, P = 0.7865) between the rearing treatments (MRS and SRS) in the fertility rate, a measure of mating competitiveness.

Burkina Fasomating competitivenesspublished 2017Malaria journaleurope_pmcdocument of 2 observations

1 visitsThe median visit number on which microscopy was still positive after treatment was 1, with a range of 1 to 3.

Burkina Fasopaludismepublished 2012Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observations

The prevalence of stunting, low-MUAC-for-age or being underweight did not differ between groups for any of the three years.

Burkina Faso · Malipaludismeobserved 2017-2019published 2022Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/s12936-022-04077-x

98.6 %The QBC-test has sensitivity of 98.6% and specificity of 99.6% according to thick and thin Giemsa-stained blood films as gold standard.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

14.3 titerAt day 180, the PfCSP-specific geometric mean titer (GMT) was 14.3 in the group receiving 100 μg ProC6C-AlOH (G2C).

Burkina Fasopaludismeobserved D180HAL · Unilimdocument of 39 observations

9.9 %The incidence of low birth weight was 9.9% under observed intermittent preventive therapy in pregnancy (IPTp) use.

Burkina Fasofaible poids de naissancepublished 2018American journal of public healtheurope_pmcdocument of 3 observationsDOI 10.2105/ajph.2017.304251

50 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 50% showed a 2-fold increase in anti-CSP IgG antibody titres post-2021 as measured by Oxford MSD assay.

Burkina Faso · Malipaludismeobserved post-2021HAL · Unilimdocument of 105 observations

332 patients332 patients withdrew from an observational study on dihydroartemisinin-piperaquine for uncomplicated malaria in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobserved September 2013 to April 2014published 2016Malaria journaleurope_pmcdocument of 6 observations